NCT07908329
Intradermal Influenza Vaccination
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Change in antibody titer concentration to vaccination-Blood
Timeframe: Day 0 and Day 28
Change in antibody titer concentration to vaccination-Skin
Timeframe: Day 0 and Day 28
Secondary (1)
Change in antibody titer concentration to vaccination
Arms and interventions
HealthyActive comparator
Healthy participants will receive either intramuscular or intradermal flu vaccination.
Cancer (Exploratory Arm)Other
Cancer patients about to undergo Immune Checkpoint Inhibitor (ICI) therapy will receive either intramuscular or intradermal flu vaccination.
Post acute infection syndrome (PAIS) (Exploratory Arm)Other
PAIS patients will receive either intramuscular or intradermal flu vaccination
Devices: MicronJet
Biologicals: Fluzone® Quadrivalent, Fluzone® High Dose Quadrivalent
Sites
1 site in 1 country
- Church Street Research UnitNew Haven, Connecticut, United States